We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of ITCI yet.

ITCI Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q1 2026, worth a combined $2.54K — unchanged from a quarter earlier.

Fund positioning in ITCI was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Intra-Cellular Therapies Inc. (ITCI) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $2.54K of Intra-Cellular Therapies Inc. stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Intra-Cellular Therapies Inc. positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.